The Southern Medical Journal (SMJ) is the official, peer-reviewed journal of the Southern Medical Association. It has a multidisciplinary and inter-professional focus that covers a broad range of topics relevant to physicians and other healthcare specialists.
SMJ // Article
Review Article
Psychiatric Condition Management in Primary Care for Adults with Intellectual and Developmental Disabilities
Abstract
Psychiatric conditions are prevalent among adults with intellectual and developmental disabilities (IDDs), with studies estimating that 33% of this population experiences psychiatric disorders such as mood, anxiety, and behavioral issues. These rates are significantly higher than the general population, underscoring the need for proper management within primary care settings. Although the integration of mental health services into primary care is increasing, general practitioners often report a lack of training and time to treat psychiatric conditions in adults with IDDs. Collaborative care models, involving partnerships between primary care providers and mental health specialists, have emerged as a promising solution, offering tailored, patient-centered treatment. Barriers like diagnostic overshadowing, communication challenges, and stigmatization hinder access to appropriate care, however. In recent years, the inclusion of genetic testing in psychiatric care has gained traction, especially in managing IDDs associated with specific genetic conditions like fragile X syndrome and DiGeorge syndrome. Genetic testing can help identify the underlying causes of psychiatric symptoms, offering valuable insights into appropriate treatment pathways. Pharmacogenetic insights provided by genetic testing can guide more personalized medication management, reducing adverse effects and improving outcomes. Effective management of psychiatric conditions in adults with IDDs requires further research, particularly randomized controlled trials, to establish evidence-based treatment approaches. Expanding research on interventions, including psychotherapy, pharmacotherapy, and genetic testing, is essential to improve patient outcomes in this underserved population.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
References
1. Schalock RL, Luckasson R, Tassé MJ. An Overview of Intellectual Disability: Definition, Diagnosis, Classification, and Systems of Supports (12th ed.). Am J Intellect Dev Disabil 2021;126(6):439–442. doi:10.1352/1944-7558-126.6.4391.
2. García-Domínguez L, Navas P, Verdugo MÁ, et al. Chronic Health Conditions in Aging Individuals with Intellectual Disabilities. IJERPH 2020;17(9):3126. doi:10.3390/ ijerph17093126.
3. Pimlott N. Aging with intellectual and developmental disabilities: Family physicians can make a difference. Can Fam Phys 2019;65(Suppl 1).
4. Moreno L, Sousa A. Integrating mental health services into primary health care – a review of challenges and outcomes in the international setting. Eur Psychiatr 2021;64(S1). doi:10.1192/ j.eurpsy.2021.1076.
5. Lineberry S, Bogenschutz M, Broda M, et al. Co-Occurring Mental Illness and Behavioral Support Needs in Adults with Intellectual and Developmental Disabilities. Community Ment Health J 2023;59(6):1119–1128. doi:10.1007/s10597-023-01091-4.
6. Quintero M, Flick S. Co-Occurring Mental Illness and Developmental Disabilities. Social Work Today 2010;10(5):6.
7. Fleury MJ, Imboua A, Aubé D, et al. General practitioners’ management of mental disorders: A rewarding practice with considerable obstacles. BMC Fam Pract 2012;13(1):19. doi:10. 1186/1471-2296-13-19.
8. Archer J, Bower P, Gilbody S, et al. Collaborative care for depression and anxiety problems. Cochrane Common Mental Disorders Group, ed. Cochrane Database Syst Rev 2012; 2012(10). doi:10.1002/14651858.CD006525.pub2.
9. Raney LE. Integrating Primary Care and Behavioral Health: The Role of the Psychiatrist in the Collaborative Care Model. Am J Psychiatry 2015;172(8):721–728. doi:10.1176/appi.ajp. 2015.15010017.
10. Poghosyan L, Norful AA, Ghaffari A, et al. Mental health delivery in primary care: The perspectives of primary care providers. Archives of Psychiatric Nursing 2019;33(5):63–67. doi:10.1016/j.apnu.2019.08.001.
11. Weise J, Pollack A, Britt H, et al. Primary health care for people with an intellectual disability: an exploration of consultations, problems identified, and their management in Australia. J Intellect Disabil Res 2017;61(5):399–410. doi:10.1111/jir.12352.
12. Mason J, Scior K. ‘Diagnostic Overshadowing’ Amongst Clinicians Working with People with Intellectual Disabilities in the UK. Research Intellect Disabil 2004;17(2):85–90. doi:10. 1111/j.1360-2322.2004.00184.x.
13. Grier E, Abells D, Casson I, et al. Managing complexity in care of patients with intellectual and developmental disabilities: Natural fit for the family physician as an expert generalist. Can Fam Phys 2018;64(Suppl 2) .
14. Ned L, Velarde MR, Singh S, et al. The Routledge International Handbook of Disability and Global Health. Milton Park, UK: Routledge; 2024.
15. Wirtz J, Ailey S. Patient outcomes associated with tailored hospital programs for intellectual disabilities. Am J Manag Care 2020;26(3). doi:10.37765/ajmc.2020.42640.
16. Jones J, Blinkhorn A, McQueen M, et al. The adaptation and feasibility of dialectical behaviour therapy for adults with intellectual developmental disabilities and transdiagnoses: A pilot community-based randomized controlled trial. Research Intellect Disabil 2021;34(3): 805–817. doi:10.1111/jar.12860.
17. Cooper SA, Smiley E, Morrison J, et al. Mental ill-health in adults with intellectual disabilities: prevalence and associated factors. Br J Psychiatry 2007;190:27–35. doi:10.1192/ bjp.bp.106.022483.
18. Bakken TL, Helvershou SB, Høidal SH, et al. Mental illness with intellectual disabilities and autism spectrum disorders. In: Hemmings C, Bouras N, eds. Psychiatric and Behavioral Disorders in Intellectual and Developmental Disabilities. 3rd ed. Cambridge, UK: Cambridge University Press; 2015:119–128. doi:10.1017/CBO9781107588714.012.
19. Hermans H, Evenhuis HM. Factors associated with depression and anxiety in older adults with intellectual disabilities: results of the healthy ageing and intellectual disabilities study. Int J Geriatr Psychiatry 2013;28(7):691–699. doi:10.1002/gps.3872.
20. Dell’Armo K, Tassé MJ. Diagnostic Overshadowing of Psychological Disorders in People With Intellectual Disability: A Systematic Review. Am J Intellect Dev Disabil 2024;129(2): 116–134. doi:10.1352/1944-7558-129.2.116.
21. Cain NN, Davidson PW, Burhan AM, et al. Identifying bipolar disorders in individuals with intellectual disability. J Intellect Disabil Res 2003;47(Pt 1):31–38. doi:10.1046/j.1365-2788. 2003.00458.x.
22. Skokauskas N, Sweeny E, Meehan J, et al. Mental health problems in children with Prader-Willi syndrome. J Can Acad Child Adolesc Psychiatry 2012;21(3):194–203.
23. Bordeianu MA, Smith DL. Depression Treatment Options for Individuals With Developmental Disabilities. J Nurse Practitioners 2022;18(9):976–982. doi:10.1016/j.nurpra. 2022.07.009.
24. Asdaq SMB, Alshehri S, Alajlan SA, et al. Depression in persons with disabilities: a scoping review. Front Public Health 2024;12:1383078. doi:10.3389/fpubh.2024.1383078.
25. Hermans H, Beekman ATF, Evenhuis HM. Prevalence of depression and anxiety in older users of formal Dutch intellectual disability services. J Affect Disord 2013;144(1-2):94–100. doi:10.1016/j.jad.2012.06.011.
26. Beasley J. Integrated Mental Health Treatment Guidelines for Prescribers in Intellectual and Developmental Disabilities. https://iod.unh.edu/sites/default/files/media/2022-05/integrated_mental_health_treatment_guidelines_for_prescribers_in_intellectual_and_developmental_disabilities_2021_0.pdf. Published 2021. Accessed September 14, 2024.
27. Storch EA, Lewin AB, Collier AB, et al. A randomized controlled trial of cognitive-behavioral therapy versus treatment as usual for adolescents with autism spectrum disorders and comorbid anxiety: CBT for Adolescents with ASD and Anxiety. Depress Anxiety 2015;32(3): 174–181. doi:10.1002/da.22332.
28. Ugwu GC, Ugwuanyi CS, Okeke CIO, et al. Efficacy of Rational Emotive Behavior Therapy on Depression Among Children with Learning Disabilities: Implications for Evaluation in Science Teaching. Journal of Rational-Emotive & Cognitive-Behavior Therapy 2022;40(2): 313–333. doi:10.1007/s10942-021-00417-z.
29. Bakken TL. Psychosocial treatment of major depression in people with intellectual disabilities. Improvements within the last four decades: points of view. Int J Dev Disabil 2021; 67(5):366–370. doi:10.1080/20473869.2021.1969498.
30. Dankner N, Dykens EM. Anxiety in Intellectual Disabilities. In: International Review of Research in Developmental Disabilities. Vol 42. New York: Elsevier; 2012:57–83. doi:10. 1016/B978-0-12-394284-5.00003-6.
31. Einfeld SL, Piccinin AM, Mackinnon A, et al. Psychopathology in Young People With Intellectual Disability. JAMA 2006;296(16):1981–1989. doi:10.1001/jama.296.16.1981.
32. Gothelf D, Penniman L, Gu E, et al. Developmental trajectories of brain structure in adolescents with 22q11.2 deletion syndrome: a longitudinal study. Schizophr Res 2007; 96(1-3):72–81. doi:10.1016/j.schres.2007.07.021.
33. Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62(6):617–627. doi:10.1001/archpsyc.62.6.617.
34. Emerson E, Hatton C. Mental health of children and adolescents with intellectual disabilities in Britain. Br J Psychiatry 2007;191(6):493–499. doi:10.1192/bjp.bp.107.038729.
35. Reiss S. Prevalence of dual diagnosis in community-based day programs in the Chicago metropolitan area. Am J Ment Retard 1990;94(6):578–585.
36. Dekker MC, Koot HM. DSM-IV Disorders in Children With Borderline to Moderate Intellectual Disability. I: Prevalence and Impact. JAACAP 2003;42(8):915–922. doi:10.1097/ 01.CHI.0000046892.27264.1A.
37. Trollor JN, Salomon C, Franklin C. Prescribing psychotropic drugs to adults with an intellectual disability. Aust Prescr 2016;39(4):126–130. doi:10.18773/austprescr.2016.048.
38. Dagnan D, Jackson I, Eastlake L. A systematic review of cognitive behavioural therapy for anxiety in adults with intellectual disabilities. J Intellect Disabil Res 2018;62(11):974–991. doi:10.1111/jir.12548.
39. Fynn G, Porter M, Borchard T, et al. The effectiveness of cognitive behavioural therapy for individuals with an intellectual disability and anxiety: a systematic review. J Intellect Disabil Res 2023;67(9):816–841. doi:10.1111/jir.13046.
40. Hagopian LP, Jennett HK. Behavioral Assessment and Treatment of Anxiety in Individuals with Intellectual Disabilities and Autism. J Dev Phys Disabil 2008;20(5):467–483. doi:10. 1007/s10882-008-9114-8.
41. Lepri A, Zaffini O, Tinarelli C, et al. Anxiety Disorders in People with Intellectual Disabilities: the Best Treatment for Properly Modulate Activities of Daily Living. Psychiatr Danub 2023; 35(Suppl 2):182–184.
42. Dekker MC, Koot HM, van der Ende J, et al. Emotional and behavioral problems in children and adolescents with and without intellectual disability. J Child Psychol Psychiatry 2002; 43(8):1087–1098. doi:10.1111/1469-7610.00235.
43. Siegel M, McGuire K, Veenstra-VanderWeele J, et al. Practice Parameter for the Assessment and Treatment of Psychiatric Disorders in Children and Adolescents With Intellectual Disability (Intellectual Developmental Disorder). J Am Acad Child Adolesc Psychiatry 2020; 59(4):468–496. doi:10.1016/j.jaac.2019.11.018.
44. Shillington A, Lamy M, Dominick KC, et al. A Collaborative Psychiatric-Genetics Inpatient Care Delivery Model Improves Access to Clinical Genetic Evaluation, Testing, and Diagnosis for Patients With Neurodevelopmental Disorders. Front Genet 2022;13:901458. doi:10.3389/fgene.2022.901458.
45. Savatt JM, Myers SM. Genetic Testing in Neurodevelopmental Disorders. Front Pediatr 2021; 9:526779. doi:10.3389/fped.2021.526779.
46. Cornish KM, Turk J, Wilding J, et al. Annotation: Deconstructing the attention deficit in fragile X syndrome: a developmental neuropsychological approach. J Child Psychol Psychiatry 2004;45(6):1042–1053. doi:10.1111/j.1469-7610.2004.t01-1-00297.x.
47. Hagerman RJ, Berry-Kravis E, Kaufmann WE, et al. Advances in the treatment of fragile X syndrome. Pediatrics 2009;123(1):378–390. doi:10.1542/peds.2008-0317.
48. Hessl D, Tassone F, Cordeiro L, et al. Brief report: aggression and stereotypic behavior in males with fragile X syndrome—moderating secondary genes in a “single gene” disorder. J Autism Dev Disord 2008;38(1):184–189. doi:10.1007/s10803-007-0365-5.
49. Hippman C, Nislow C. Pharmacogenomic Testing: Clinical Evidence and Implementation Challenges. J Pers Med 2019;9(3):40. doi:10.3390/jpm9030040.
50. Karayiorgou M, Simon TJ, Gogos JA. 22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia. Nat Rev Neurosci 2010;11(6):402–416. doi: 10.1038/nrn2841.
51. Bassett AS, Chow EW. 22q11 deletion syndrome: a genetic subtype of schizophrenia. Biol Psychiatry 1999;46(7):882–891. doi:10.1016/s0006-3223(99)00114-6.
52. Herbert D, Neves-Pereira M, Baidya R, et al. Genetic testing as a supporting tool in prescribing psychiatric medication: design and protocol of the IMPACT study. J Psychiatr Res 2018;96:265–272. doi:10.1016/j.jpsychires.2017.09.002.
53. Austin-Zimmerman I, Wronska M, Wang B, et al. The Influence of CYP2D6 and CYP2C19 Genetic Variation on Diabetes Mellitus Risk in People Taking Antidepressants and Antipsychotics. Genes (Basel) 2021;12(11):1758. doi:10.3390/genes12111758.
54. Whitehouse RM, Tudway JA, Look R, et al. Adapting Individual Psychotherapy for Adults with Intellectual Disabilities: A Comparative Review of the Cognitive–Behavioural and Psychodynamic Literature. Res Intellect Disabil 2006;19(1):55–65. doi:10.1111/j.1468-3148. 2005.00281.x.
55. Haddock G, Lobban F, Hatton C, et al. Cognitive–behaviour therapy for people with psychosis and mild intellectual disabilities: a case series. Clin Psychol Psychother 2004;11(4):282–298. doi:10.1002/cpp.414.
56. Santos FH, Zurek J, Janicki MP. Efficacy of Healthy Aging Interventions for Adults With Intellectual and Developmental Disabilities: A Systematic Review. Gerontologist 2022;62(4). doi:10.1093/geront/gnaa192.
57. Matthews L, Mitchell F, Stalker K, et al. Process evaluation of the Walk Well study: a cluster-randomised controlled trial of a community-based walking programme for adults with intellectual disabilities. BMC Public Health 2016;16(1):527. doi:10.1186/s12889-016-3179-6.
